Medical Oncologist
CION Cancer Clinics
Why ordinary chemotherapy barely works in liver cancer | CION Cancer Clinics
Standard chemotherapy works poorly for hepatocellular carcinoma because the cancer cells push the drugs out, and the scarred liver behind most of these cancers handles them badly. That is why oncologists now use immunotherapy combinations and targeted tablets instead. This page explains the reasons, where chemotherapy still helps, and why cancer that spread to the liver from elsewhere is a different story. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Why does chemotherapy not work well for liver cancer?
- What makes HCC so hard for chemotherapy to reach?
- Where does chemotherapy still play a part in liver tumours?
- If chemotherapy is weak, why is it used inside TACE?
- What families often think about chemotherapy and the liver
- What this page cannot tell you
- Common questions about chemotherapy for liver cancer
The short answer
Why does chemotherapy not work well for liver cancer?
Hepatocellular carcinoma (HCC, the cancer that starts in the liver cells) is naturally resistant to most standard chemotherapy drips. On top of that, the cirrhosis that usually sits behind it makes the liver less able to handle those drugs, so side effects are heavier and benefit is small.
Which liver cancer this is about
This page is about primary liver cancer that starts in the liver itself. If your report says the cancer spread to the liver from the bowel, breast, stomach or pancreas, it is secondary liver cancer. Chemotherapy often works well for those, because it is chosen for the original cancer. Bowel cancer that has spread to the liver is covered on our colon cancer pages.
What replaced it
For HCC that cannot be removed or treated locally, the main medicines today are immunotherapy combinations and targeted tablets. These were tested against older treatments and did better, which is why your oncologist may not offer a chemotherapy drip at all. That is a deliberate choice, not a gap in your care.
Not being offered chemotherapy does not mean nothing can be done. It means other medicines suit this cancer better.The reasons
What makes HCC so hard for chemotherapy to reach?
Three problems stack on top of each other. Any one of them would make chemotherapy weaker. Together they explain why it was replaced.
The cancer cells push the drug out
Liver cells are built to clear toxins from the blood. HCC cells keep that ability, and use pumps in their walls to push chemotherapy drugs back out before they can do damage.
The liver itself is already damaged
Most people with HCC also have cirrhosis, scarring of the liver from hepatitis B, hepatitis C, alcohol or fatty liver. A scarred liver clears many drugs slowly, so they build up and cause more harm.
Blood counts start low
Cirrhosis often enlarges the spleen, which traps blood cells. Many patients begin with a low platelet count before any treatment.
- Higher bleeding risk
- Higher infection risk
- Less room for chemotherapy to lower counts further
The trials were disappointing
When drugs such as doxorubicin were tested in HCC, few tumours shrank and people did not clearly live longer. Newer medicines later beat the older approach in proper trials.
Not sure whether this applies to you?
Ask an oncologistSide by side
Where does chemotherapy still play a part in liver tumours?
Situation
Role of chemotherapy
HCC treated with a drip into a vein
Small. Rarely the first choice today
HCC treated with TACE
The drug goes straight into the tumour's artery, so far less reaches the body
Bile duct cancer (cholangiocarcinoma)
A main treatment, usually combined with immunotherapy
Cancer spread to the liver from elsewhere
Often central, chosen for the original cancer
Hepatoblastoma in children
Central, and works well. A different disease
Getting the drug closer
If chemotherapy is weak, why is it used inside TACE?
TACE (transarterial chemoembolisation) places chemotherapy directly into the artery feeding the tumour, then blocks that artery. The tumour gets a much stronger dose than a drip could ever deliver, and is starved of blood at the same time. The rest of the body receives far less.
It works for a different group
TACE is used for tumours that are still confined to the liver, in a liver that works reasonably well. It is not a treatment for cancer that has spread beyond the liver. CION coordinates TACE through NABH-accredited partner hospitals, and how TACE is done is explained in our procedures section.
Infusion straight into the liver
Some teams, particularly in East Asia, give chemotherapy through a small tube placed in the liver artery for several sessions. This is called hepatic arterial infusion chemotherapy. It is mainly used when the tumour has grown into the portal vein. Evidence is still developing, and it is not widely offered in India.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What families often think about chemotherapy and the liver
"If the doctor is not giving chemotherapy, they have given up."
For HCC, the newer medicines are the stronger treatment. Choosing them over chemotherapy is the active choice, and it follows what international guidelines recommend.
"Chemotherapy will finish off the liver."
In someone whose liver is already badly scarred, standard chemotherapy can be harmful, which is one reason it is avoided. In a fitter liver, and in secondary liver cancer, it is often given safely with close checks. Read more on this common fear.
"Stronger chemotherapy would have worked better."
Raising the dose does not overcome the cancer's ability to push the drug out. It mainly raises side effects in a liver that cannot clear them.
"A relative's liver cancer was treated with chemotherapy, so ours should be too."
That relative may have had cancer spread to the liver from elsewhere, or bile duct cancer. Those are different diseases with different medicines.
Being straight with you
What this page cannot tell you
It cannot tell you whether chemotherapy has a place in your own plan. Some tumours are mixed, part HCC and part bile duct cancer, and some people have rarer liver cancers that behave differently. Only your biopsy report and the tumour board can sort out which applies.
Who this does not apply to
Everything above is about HCC. It does not apply to children with hepatoblastoma, to bile duct cancer, or to cancer that has spread to the liver from another organ. In each of those, chemotherapy is often an important treatment and should not be refused because of what you read here.
When there is no other choice
Occasionally, when newer medicines cannot be used or obtained, oncologists still consider chemotherapy for HCC. The evidence for this is modest, and the reasons should be explained to you clearly. The current main options are set out in systemic treatment for liver cancer today.
If you have been offered chemotherapy for HCC and are unsure why, it is fair to ask for a second opinion. One helpline serves every CION centre.Questions we are asked
Common questions about chemotherapy for liver cancer
Is chemotherapy ever used for HCC?
Yes, but mostly inside TACE, where the drug goes straight into the tumour's artery. Chemotherapy through a vein is rarely the first choice for HCC today. It may be considered when immunotherapy and targeted tablets cannot be used, and your oncologist should explain why in your case.
What is given instead of chemotherapy?
Usually an immunotherapy combination such as atezolizumab plus bevacizumab, or durvalumab plus tremelimumab. Targeted tablets such as lenvatinib or sorafenib are used when immunotherapy is not suitable. The choice depends on your liver function, any bleeding risk and other health problems.
Is my parent's cancer primary or secondary?
The biopsy report or the oncologist's letter will say. Primary liver cancer is usually written as hepatocellular carcinoma or HCC. Secondary cancer is often written as liver metastases from the named original organ. If it is unclear, ask the oncologist to tell you in plain words.
Why does bile duct cancer get chemotherapy if HCC does not?
Bile duct cancer starts in different cells, which respond better to drugs such as gemcitabine and cisplatin. Combining these with immunotherapy is a standard first treatment. These tumours should also have their DNA tested, because some have targeted options. See our page on biliary cancer treatment.
Can chemotherapy damage a cirrhotic liver?
It can. A scarred liver clears many drugs slowly, and low platelets raise the risk of bleeding. That is why doctors check Child-Pugh grade, bilirubin and blood counts before any drug, and why they lean towards medicines tested specifically in people with HCC.
Are immunotherapy and targeted tablets not just chemotherapy?
No. Chemotherapy kills cells that divide quickly. Immunotherapy helps your own immune system recognise the cancer, and targeted tablets block signals and blood supply the tumour needs. They have different side effects. Many families use the word chemotherapy for all three, which causes confusion.
Are the newer medicines available in Hyderabad?
Several immunotherapy drugs and targeted tablets are available in India, some as lower-priced generic or biosimilar versions. Availability changes. CION gives immunotherapy and targeted therapy at its centres and can tell you what is obtainable now and whether assistance programmes apply.
Should we get a second opinion?
If you have been offered standard chemotherapy for HCC without a clear reason, a second opinion is reasonable. Bring the biopsy report, recent scans and blood tests. Call the CION helpline to arrange a review by our tumour board at the nearest centre.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Chemotherapy for Liver Cancer
- American Cancer Society — Embolization Therapy for Liver Cancer
- Cancer Research UK — Treatment for liver cancer
- Cancer Research UK — Secondary liver cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Systemic treatment for liver cancer: the options todayWhat is used instead, and in what orderAtezolizumab plus bevacizumab for liver cancerThe usual first choice for advanced HCCHepatic arterial infusion chemotherapyChemotherapy delivered straight into the liverMyth: chemotherapy will finish the liver offThe fear families raise most often
Talk to us
Not sure why chemotherapy was or was not offered?
Bring the biopsy report and scans and our oncologists will explain which medicines suit this cancer and this liver. One helpline serves every CION centre.